Manufacturing of recombinant therapeutic proteins in microbial systems
- PMID: 16892246
- DOI: 10.1002/biot.200500051
Manufacturing of recombinant therapeutic proteins in microbial systems
Abstract
Recombinant therapeutic proteins have gained enormous importance for clinical applications. The first recombinant products have been produced in E. coli more than 20 years ago. Although with the advent of antibody-based therapeutics mammalian expression systems have experienced a major boost, microbial expression systems continue to be widely used in industry. Their intrinsic advantages, such as rapid growth, high yields and ease of manipulation, make them the premier choice for expression of non-glycosylated peptides and proteins. Innovative product classes such as antibody fragments or alternative binding molecules will further expand the use of microbial systems. Even more, novel, engineered production hosts and integrated technology platforms hold enormous potential for future applications. This review summarizes current applications and trends for development, production and analytical characterization of recombinant therapeutic proteins in microbial systems.
Comment in
-
The art of bioprocessing.Biotechnol J. 2006 Feb;1(2):111. doi: 10.1002/biot.200690030. Biotechnol J. 2006. PMID: 16892235 No abstract available.
Similar articles
-
Antibodies and genetically engineered related molecules: production and purification.Biotechnol Prog. 2004 May-Jun;20(3):639-54. doi: 10.1021/bp030070k. Biotechnol Prog. 2004. PMID: 15176864 Review.
-
Proteomic profiling of Escherichia coli proteins under high cell density fed-batch cultivation with overexpression of phosphogluconolactonase.Biotechnol Prog. 2005 Sep-Oct;21(5):1401-11. doi: 10.1021/bp050048m. Biotechnol Prog. 2005. PMID: 16209543
-
Engineering cell physiology to enhance recombinant protein production in Escherichia coli.Appl Microbiol Biotechnol. 2007 Sep;76(3):521-32. doi: 10.1007/s00253-007-1039-0. Epub 2007 Jun 15. Appl Microbiol Biotechnol. 2007. PMID: 17571257 Review.
-
Plant cell cultures for the production of recombinant proteins.Nat Biotechnol. 2004 Nov;22(11):1415-22. doi: 10.1038/nbt1027. Nat Biotechnol. 2004. PMID: 15529167 Review.
-
The rapid discovery of engineered antibodies.IDrugs. 2007 Aug;10(8):562-5. IDrugs. 2007. PMID: 17665332 Review.
Cited by
-
Essential factors, advanced strategies, challenges, and approaches involved for efficient expression of recombinant proteins in Escherichia coli.Arch Microbiol. 2024 Mar 12;206(4):152. doi: 10.1007/s00203-024-03871-2. Arch Microbiol. 2024. PMID: 38472371 Review.
-
Construction of recombinant Lactococcus expressing thymosin and interferon fusion protein and its application as an immune adjuvant.Microb Cell Fact. 2024 Feb 6;23(1):40. doi: 10.1186/s12934-024-02308-1. Microb Cell Fact. 2024. PMID: 38321474 Free PMC article.
-
Ileal inflammation is reduced due to treatment with a metalloprotease from BmooMP-α-I snake venom in an experimental model of Toxoplasma gondii infection.Parasitol Res. 2023 Dec 22;123(1):65. doi: 10.1007/s00436-023-08033-9. Parasitol Res. 2023. PMID: 38133827
-
Yeast Surface Display Methodology for the Characterization of Food Allergens In Situ.Methods Mol Biol. 2024;2717:41-63. doi: 10.1007/978-1-0716-3453-0_4. Methods Mol Biol. 2024. PMID: 37737977
-
Production of recombinant scorpion antivenoms in E. coli: current state and perspectives.Appl Microbiol Biotechnol. 2023 Jul;107(13):4133-4152. doi: 10.1007/s00253-023-12578-1. Epub 2023 May 18. Appl Microbiol Biotechnol. 2023. PMID: 37199752 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
